Video: Clinical Advantages of Critical Diagnostics‘ Cardiac Biomarker ST2
David Stammel, 11.04.2016The results from this recent study highlights the enduring clinical utility of ST2 despite being combined with the established and widely accepted cardiac biomarkers, like NTpro BNP, in medical practice. „The best results were obtained for ST2 and high-sensitivity troponin T,“ notes Dr. Bayes-Genis, the primary investigator of the study. „Whenever we added NT-proBNP to these other two biomarkers, net reclassification improvement was reduced.“
